Range
- - -
Vol / Avg.
-/102.5K
Div / Yield
-
52 Wk
4.49 - 29.4
Mkt Cap
172.1M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.19
Shares
18.3M
Outstanding
18.3M
Total Float
17.1M
Benzinga - 3 days ago
Benzinga - 6 days ago
Benzinga - Jun 1, 2021, 8:06AM
Benzinga - May 18, 2021, 8:14AM
Benzinga - May 11, 2021, 10:30AM
Benzinga - Apr 29, 2021, 2:54PM
Benzinga - Mar 22, 2021, 12:54PM
Benzinga - Mar 22, 2021, 8:02AM
Benzinga - Mar 8, 2021, 8:27AM
Benzinga - Mar 1, 2021, 7:56AM
Benzinga - Feb 22, 2021, 8:08AM
Benzinga - Feb 9, 2021, 5:26PM
Benzinga - Feb 8, 2021, 10:07AM
Benzinga - Feb 8, 2021, 10:03AM
Benzinga - Feb 3, 2021, 12:34PM
Benzinga - Feb 3, 2021, 7:56AM
load more
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ENLVEnlivex Therapeutics4.47%172.1M

Enlivex Therapeutics Frequently Asked Questions

Q

How do I buy Enlivex Therapeutics (ENLV) stock?

A

You can purchase shares of Enlivex Therapeutics (NASDAQ: ENLV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Enlivex Therapeutics's (ENLV) competitors?

A

There are no as such competitors for Enlivex Therapeutics.

Q

What is the target price for Enlivex Therapeutics (ENLV) stock?

A

The latest price target for Enlivex Therapeutics (NASDAQ: ENLV) was reported by HC Wainwright & Co. on January 9, 2020. The analyst firm set a price target for 20.00 expecting ENLV to rise to within 12 months (a possible 112.77% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Enlivex Therapeutics (ENLV)?

A

The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $9.4 last updated Thu Jun 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Enlivex Therapeutics (ENLV) pay a dividend?

A

There are no upcoming dividends for Enlivex Therapeutics.

Q

When is Enlivex Therapeutics (NASDAQ:ENLV) reporting earnings?

A

Enlivex Therapeutics does not have any upcoming earnings scheduled.

Q

Is Enlivex Therapeutics (ENLV) going to split?

A

There is no upcoming split for Enlivex Therapeutics.

Q

What sector and industry does Enlivex Therapeutics (ENLV) operate in?

A

Enlivex Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.